APOA1 and myeloid sarcoma: In the patients with MS, the correlation between the serum levels of AOPPs and HDL3-C turned insignificant after adjusting for Model 4 only, whereas that between the serum levels of AOPPs and HDL-FC was generally rendered insignificant upon adjustment, including those between the serum levels of AOPPs and HDL-apoA-I and HDL4-apoA-I after adjustments for Models 1, 3, and 4 (Table S19).